10x Genomics Reports Q2 Growth Amid Challenges
10x Genomics sees 4% revenue growth in Q2 2024 but lowers full-year outlook due to economic headwinds affecting instrument sales.
- Latest
- Trending
10x Genomics sees 4% revenue growth in Q2 2024 but lowers full-year outlook due to economic headwinds affecting instrument sales.
Cathie Wood's ARK shifts focus, selling Ginkgo and Coinbase, while investing in 10X Genomics and Roku in a biotech-centered portfolio ...
Leading genomics company, 10x Genomics, reported a 20% revenue growth in 2023 driven by the successful launch of their Xenium ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.